Summary
Double-blind, randomized, vehicle- and comparator-controlled, multi-center trial to evaluate the efficacy and safety of LAS41007 in the treatment of actinic keratosis (NCT01265602)
Summary
Multicenter, randomized, parallel-group, double-blind, vehicle-controlled study to evaluate the efficacy and safety of PEP005 (ingenol mebutate) gel, 0.05% in patients with actinic keratoses on nonhead locations
Summary
Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data
Summary
Positive results for LEO Pharma's phase III actinic (solar) keratosis trials on the face and scalp
Summary
Positive results for LEO Pharma's phase III actinic (solar) keratosis trials on the face and scalp
Summary
Short incubation methylaminolevulinate photodynamic therapy without occlusion (NCT00926952)
Summary
A multicenter study to evaluate the efficacy and safety of PEP005 (ingenol mebutate) gel when used to treat actinic keratoses (AKs) on the non head locations (NCT00942604)
Summary
A multicenter study to evaluate the efficacy and safety of PEP005 (ingenol mebutate) gel when used to treat actinic keratoses (AKs) on the non head locations (NCT00942604)
Summary
Treating actinic keratosis with imiquimod 5% cream for 1 or 2 courses of treatment and long term clinical outcome
Summary
Safety and effectiveness study of actinic keratosis treatment following cryosurgery (NCT00894647)
This site complies with the HONcode standard for trustworthy health information: